The DOI matches its Crossref record.
THE RESTORATION OF CONDUCTION BY CENTRAL REMYELINATION
Abstract
Conduction has been examined serially through the experimental demyelinating lesion produced by the direct micro-injection of lysophatidyl choline into the cat spinal cord. Conduction was blocked during the phase of demyelination. Remyelination commenced during the latter part of the second week, and conduction through the lesion was restored in some fibres at this time. The refractory period of transmission was initially prolonged. As remyelination proceeded, conduction was restored in increasing numbers of fibres. Within three months the responses were stable and the refractory periods of transmission had returned to normal even though the new internodes were still abnormally thin and were generally shorter than normal. Restoration of conduction by remyelination is likely to contribute to recovery from compressive and traumatic lesions of the central nervous system but probably plays little part in the remissions of multiple sclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Compston, A., & Coles, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,372
Compston, A., & Coles, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08220-x · Cited by 1,743
Trigeminal neuralgia: Pathology and pathogenesis
Love, S. (2001) · Brain · doi:10.1093/brain/124.12.2347 · Cited by 866
Smith, K. J., & McDonald, W. I. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0510 · Cited by 340
Self-citationRedford, E. (1997) · Brain · doi:10.1093/brain/120.12.2149 · Cited by 326
Guest, J. D., Hiester, E. D., & Bunge, R. P. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.11.033 · Cited by 310
Remyelination in Experimental Models of Toxin-Induced Demyelination
Blakemore, W. F., & Franklin, R. J. M. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-73677-6_8 · Cited by 275
“Thus, lysolecithin lesions were made in cat and, subsequently, the rat dorsal funiculus to examine the electrophysiological properties of demyelinated and remyelinated CNS axons [35, 88 ], while the caudal cerebellar lesions were developed to allow the placement of secure in-dwelling cannula for infusion [80, 98].”
BackgroundSelf-citationExtensive remyelination of the CNS leads to functional recovery
Duncan, I. D., Brower, A., Kondo, Y., Curlee, J. F., & Schultz, R. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812500106 · Cited by 227
Remyelinating strategies for the treatment of multiple sclerosis
Stangel, M., & Hartung, H.-P. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00105-3 · Cited by 126
Gadolinium-DTPA-enhanced magnetic resonance imaging in optic neuropathies
Guy, J., Mancuso, A., Quisling, R. G., Beck, R., & Moster, M. (1990) · Ophthalmology · doi:10.1016/s0161-6420(90)32537-x · Cited by 90
Trebst, C., Heine, S., Lienenklaus, S., Lindner, M., Baumgärtner, W., Weiss, S., & Stangel, M. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0300-z · Cited by 38
Remyelinating and neuroprotective treatments in multiple sclerosis
Stangel, M. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.4.331 · Cited by 22
Remyelination in animal models of multiple sclerosis: finding the elusive grail of regeneration
Packer, D., Fresenko, E. E., & Harrington, E. P. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1207007 · Cited by 21
Metadata
- Authors
- SMITH, K. J., BLAKEMORE, W. F., & MCDONALD, W. I.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 1981
- Volume
- 104
- Issue
- 2
- Pages
- 383-404
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2116532218
- Cited by
- 183
- References
- 0
- FWCI
- 3.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.